Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebicapone in Parkinson's Disease Patients With "Wearing-off" Phenomenon
NCT03103399Phase 2Completed
- Sponsor
- BIAL
- Start
- Sep 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of nebicapone in Parkinson's disease (PD) (5 arms), sponsored by BIAL. Primary endpoint: Change from baseline in absolute "off" time at 8 weeks. Started Sep 2006; status: completed.
02
Drugs
nebicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03103399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103399.